Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...
Shares of Amgen Inc. AMGN inched 0.91% higher to $335.95 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...
False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.
In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...
Despite Ireland’s stellar biopharmaceutical success, the new president of the Irish Pharmaceutical Healthcare Association ...
As England’s Matthew Baldwin claimed the first round lead with a superb seven-under-par 65, and Shane Lowry again ...
The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.
In addition to Dr. Bachleda, members of the Eyconis Board of Directors include Dr. Cunningham, who serves as Executive Chair, Jan Mikkelsen, President & CEO of Ascendis Pharma A/S, Daniel Estes, Ph.D.
Grant Forrest was left raging by a “stupid mistake” after a sore finish cost him a chance to set the pace in the $9 million ...
High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...
In an incident-packed round, 2014 champion McIlroy broke a club midshot, had to hit a back left-handed, watched his tee shot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback